Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 30, Issue 8, Pages 787-796
Publisher
Wiley
Online
2010-07-23
DOI
10.1592/phco.30.8.787
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response to Letter by van Werkum: Proton pump inhibitors and clopidogrel: a difficult dilemma
- (2009) Jolanta M. Siller-Matula et al. AMERICAN HEART JOURNAL
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
- (2009) D. N. Juurlink et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome
- (2009) Jeremy A. Rassen et al. CIRCULATION
- Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
- (2009) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations
- (2009) Kyle J Ellis et al. PHARMACOGENOMICS
- Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy
- (2009) Christine S. Zuern et al. THROMBOSIS RESEARCH
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) et al. CIRCULATION
- The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance
- (2008) KA Kim et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel
- (2008) David S. Small et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Initial Assessment of Clinical Impact of a Drug Interaction Between Clopidogrel and Proton Pump Inhibitors
- (2008) Edmund Pezalla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
- (2008) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started